Drug recall · May 2, 2018
NEOstigmine Methylsulfate recall
Why: Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
NEOstigmine Methylsulfate (1 mg/mL) 3mg per 3mL. 3mL Single Dose Syringe. Premier Pharmacy Labs. 8265 Commercial Way Weeki Wachee, FL 34613 NDC 69623-234-14.
- Lots / codes
Lot: NEO022218SVDS BUD: 8/21/2018
- Quantity
- 600 syringes
- Company
- Premier Pharmacy Labs Inc, Weeki Wachee, FL
- Distribution
- Nationwide in the USA
- Initiated
- April 11, 2018 · Voluntary: Firm initiated
- Classified
- April 26, 2018
- Reported
- May 2, 2018
- Ended
- September 15, 2020
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Neostigmine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.